Table 5.
Standardized mortality rates in 30-day survivors.a
| Characteristic | SMR after 3 y (95% CI) | SMR after 5 y (95% CI) |
|---|---|---|
| All patients | 3.35 (2.88-3.88) | 2.77 (2.41-3.16) |
| Cancer status | ||
| Active cancer | 15.82 (12.75-19.42) | 11.63 (9.44-14.18) |
| Non-cancer | 1.94 (1.56-2.37) | 1.80 (1.50-2.14) |
| Sex | ||
| Female | 3.38 (2.75-4.12) | 2.86 (2.38-3.42) |
| Male | 3.33 (2.69-4.09) | 2.67 (2.20-3.27) |
| Age (y) | ||
| <75 | 7.25 (5.93-8.78) | 5.41 (4.50-6.46) |
| ≥75 | 2.02 (1.61-2.49) | 1.77 (1.45-2.14) |
SMR, standardized mortality rate.
a
For the calculation of SMRs, observed mortality was compared with expected mortality in the general population taking into account sex, age, and year of birth.